| 0.971 | 0.004 | 0.971 | Analgesic | | |
| 0.876 | 0.001 | 0.876 | Hematopoietic | | |
| 0.721 | 0.004 | 0.721 | Psychostimulant | | |
| 0.701 | 0.004 | 0.701 | Glutamate receptor antagonist | | |
| 0.694 | 0.005 | 0.694 | Anticonvulsant | | |
| 0.689 | 0.004 | 0.689 | Anesthetic general | | |
| 0.672 | 0.003 | 0.672 | NMDA 2B receptor antagonist | | |
| 0.603 | 0.004 | 0.603 | NMDA receptor antagonist | | |
| 0.569 | 0.005 | 0.569 | P-glycoprotein inhibitor | | |
| 0.503 | 0.003 | 0.503 | NMDA 2A receptor antagonist | | |
| 0.458 | 0.003 | 0.458 | NMDA 2C receptor antagonist | | |
| 0.456 | 0.003 | 0.456 | NMDA receptor subunit 3A antagonist | | |
| 0.434 | 0.003 | 0.434 | NMDA receptor subunit 3B antagonist | | |
| 0.404 | 0.004 | 0.404 | NMDA 2 receptor antagonist | | |
| 0.464 | 0.103 | 0.464 | Antiinflammatory | | |
| 0.347 | 0.005 | 0.347 | Analgesic, opioid | | |
| 0.37 | 0.075 | 0.37 | GABA C receptor rho-3 antagonist | | |
| 0.301 | 0.044 | 0.301 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.369 | 0.131 | 0.369 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | | |
| 0.206 | 0.004 | 0.206 | Nociceptin (N/OFQ) receptor antagonist | | |
| 0.288 | 0.104 | 0.288 | Calcium channel activator | | |
| 0.221 | 0.058 | 0.221 | Neurotrophic factor enhancer | | |
| 0.246 | 0.091 | 0.246 | 5 Hydroxytryptamine release stimulant | | |
| 0.22 | 0.073 | 0.22 | RNA-directed DNA polymerase inhibitor | | |
| 0.26 | 0.118 | 0.26 | Cholesterol antagonist | | |
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | | |
| 0.176 | 0.041 | 0.176 | Calcium channel blocker | | |
| 0.18 | 0.054 | 0.18 | Arachidonic acid antagonist | | |
| 0.126 | 0.002 | 0.126 | NMDA receptor phencyclidine site antagonist | | |
| 0.224 | 0.099 | 0.224 | Interleukin agonist | | |
| 0.221 | 0.101 | 0.221 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.13 | 0.014 | 0.13 | Calcium channel L-type blocker | | |
| 0.157 | 0.041 | 0.157 | Pregnane X receptor agonist | | |
| 0.274 | 0.162 | 0.274 | MAP kinase kinase 6 inhibitor | | |
| 0.146 | 0.035 | 0.146 | Calcium channel (voltage-sensitive) blocker | | |
| 0.189 | 0.083 | 0.189 | 5 Hydroxytryptamine 3E antagonist | | |
| 0.286 | 0.181 | 0.286 | 5 Hydroxytryptamine release inhibitor | | |
| 0.136 | 0.031 | 0.136 | Creatine kinase inhibitor | | |
| 0.112 | 0.011 | 0.112 | Antidiuretic hormone antagonist | | |
| 0.11 | 0.02 | 0.11 | Protein kinase B beta inhibitor | | |
| 0.097 | 0.009 | 0.097 | Potassium channel intermediate-conductance Ca-activated blocker | | |
| 0.205 | 0.125 | 0.205 | 5 Hydroxytryptamine 1E antagonist | | |
| 0.09 | 0.015 | 0.09 | Opioid agonist | | |
| 0.153 | 0.083 | 0.153 | Sigma receptor agonist | | |
| 0.109 | 0.042 | 0.109 | Opioid antagonist | | |
| 0.103 | 0.038 | 0.103 | Glutamate release inhibitor | | |
| 0.087 | 0.024 | 0.087 | NMDA receptor glycine site agonist | | |
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | | |
| 0.185 | 0.121 | 0.185 | Peptidyltransferase inhibitor | | |
| 0.096 | 0.033 | 0.096 | Opioid mu receptor antagonist | | |
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | | |
| 0.07 | 0.01 | 0.07 | Potassium channel (ATP-sensitive) activator | | |
| 0.077 | 0.018 | 0.077 | Dopamine transporter inhibitor | | |
| 0.142 | 0.085 | 0.142 | GABA C receptor rho-2 antagonist | | |
| 0.176 | 0.119 | 0.176 | Aldehyde oxidase inhibitor | | |
| 0.156 | 0.101 | 0.156 | Succinate dehydrogenase inhibitor | | |
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | | |
| 0.193 | 0.144 | 0.193 | MAP kinase kinase 3 inhibitor | | |
| 0.136 | 0.091 | 0.136 | Ca2+-transporting ATPase inhibitor | | |
| 0.075 | 0.032 | 0.075 | NMDA receptor agonist | | |
| 0.139 | 0.097 | 0.139 | CF transmembrane conductance regulator agonist | | |
| 0.176 | 0.138 | 0.176 | Nitric-oxide synthase stimulant | | |
| 0.084 | 0.051 | 0.084 | T cell inhibitor | | |
| 0.125 | 0.093 | 0.125 | CC chemokine 6 receptor antagonist | | |
| 0.103 | 0.072 | 0.103 | 5 Hydroxytryptamine 3A agonist | | |
| 0.115 | 0.083 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | | |
| 0.09 | 0.06 | 0.09 | Potassium channel activator | | |
| 0.097 | 0.067 | 0.097 | GABA C receptor rho-1 antagonist | | |
| 0.033 | 0.004 | 0.033 | Somatostatin 3 agonist | | |
| 0.082 | 0.053 | 0.082 | Glycine receptor antagonist | | |
| 0.083 | 0.054 | 0.083 | Opioid kappa receptor antagonist | | |
| 0.096 | 0.068 | 0.096 | Anabolic | | |
| 0.041 | 0.013 | 0.041 | Histamine H3 receptor agonist | | |
| 0.108 | 0.08 | 0.108 | Interleukin 8 antagonist | | |
| 0.058 | 0.037 | 0.058 | Pregnane X receptor antagonist | | |
| 0.092 | 0.071 | 0.092 | UDP-glucose 4-epimerase inhibitor | | |
| 0.031 | 0.016 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | | |
| 0.052 | 0.038 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | | |
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | | |
| 0.017 | 0.004 | 0.017 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | | |
| 0.027 | 0.014 | 0.027 | NMDA receptor glycine site antagonist | | |
| 0.033 | 0.021 | 0.033 | Somatostatin agonist | | |
| 0.072 | 0.06 | 0.072 | Vanilloid 4 agonist | | |
| 0.095 | 0.086 | 0.095 | GABA C receptor antagonist | | |
| 0.123 | 0.117 | 0.123 | Adenylate cyclase stimulant | | |
| 0.063 | 0.057 | 0.063 | Protein kinase B alpha inhibitor | | |
| 0.063 | 0.058 | 0.063 | Glutamate (mGluR6) antagonist | | |
| 0.051 | 0.047 | 0.051 | Dihydroorotate oxidase inhibitor | | |
| 0.068 | 0.065 | 0.068 | GABA aminotransferase inhibitor | | |
| 0.04 | 0.037 | 0.04 | Nerve growth factor antagonist | | |
| 0.09 | 0.089 | 0.09 | Cystathionine beta-synthase inhibitor | | |